UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF MICHIGAN

SOUTHERN DIVISION

Ziebart International Corp.,

Plaintiff,

v.

Z Technologies Corp.,

Defendant.

________________________________/

Case No. 15-cv-11745

Judith E. Levy

United States District Judge

Mag. Judge Anthony P. Patti

OPINION AND ORDER DENYING DEFENDANT’S MOTION FOR 

SUMMARY JUDGMENT [93] AND DENYING PLAINTIFF’S 

MOTION FOR SUMMARY JUDGMENT [95]

This case arises out of the fractured business relationship between 

Ziebart International, Corp. and Z Technologies, Corp. Pursuant to leave 

of the Court, the parties have filed a second round of summary judgment 

motions. For the reasons stated below, both plaintiff’s and defendant’s 

motions for summary judgment are denied. 

I. Background

In this case, the Court permitted the parties to engage in two 

rounds of summary judgment briefing. In an opinion and order dated 

January 23, 2017, the Court denied defendant’s motion for summary 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 1 of 19 Pg ID 2532
2

judgment, granted in part and denied in part plaintiff and third party 

defendant Pure Asphalt Corp.’s motion for summary judgment, and 

granted Pure Asphalt Corp.’s motion for judgment on the pleadings. 

(Dkt. 80.) In that opinion and order, the Court recounted the facts of this 

case, and will primarily rely on that recitation of facts here. See Ziebart 

Int'l Corp. v. Z Techs. Corp., No. 15-CV-11745, 2017 WL 282395 (E.D. 

Mich. Jan. 23, 2017).

In 1996, plaintiff sold its chemical subsidiary, Ziebart Products 

Group, Inc. (“ZPG”) to The Sentry Corporation, which then became 

known as Z Technologies, Inc. (Dkt. 1 at 6; Dkt. 56-2 at 8.) As part of the 

sale, the parties entered into the following agreements that addressed, 

among other things, use of trade names, trademarks, disclosure of 

information, and other intellectual property: Asset Purchase Agreement; 

License Agreement; Non-Competition and Non-Disclosure Agreement; 

and Supply Agreement. (Dkt. 1 at 4–6; Dkt. 52 at 19–23; Dkt. 66-10 at 2.)

The primary agreement was the Asset Purchase Agreement 

(“APA”). This agreement transferred all of ZPG’s manufacturing 

equipment, property, and know-how to defendant, including the 

equipment and processes for manufacturing the product known as 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 2 of 19 Pg ID 2533
3

Formula Q. In its exact language, it involved the sale of “all of the assets 

of Seller currently used by Seller at the Facility or elsewhere in 

connection with the business conducted at the Facility which are 

necessary, important or useful to the business conducted at the facility 

as set forth in Schedule 2.1,” where “Seller” was defined as ZPG. (Dkt. 

93-1 at 11-12.) Any reference to Ziebart in the APA used the name 

Ziebart. (Id. at 7.) Importantly, neither party could locate and produce 

Schedule 2.1 during the course of this litigation, and the parties disagree 

about its contents.

Pursuant to the License Agreement, defendant was permitted to 

license and use specified trademarks, service marks, and trade names 

owned by plaintiff for sale to automobile manufacturers. (Dkt. 56-4 at 3–

4.) The intellectual property to be licensed to defendant was supposed to 

be attached to the License Agreement as Exhibit A, but neither party 

provided it to the Court.

The parties also entered into a Supply Agreement, which generally

made defendant the exclusive manufacturer of Formula Q, among other 

products, for sale by plaintiff. (Dkt. 56-6 at 3.) That agreement reserved 

plaintiff’s right to control the quality of the chemical it purchased from 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 3 of 19 Pg ID 2534
4

defendant, reject shipments that did not meet its standards, and find an 

alternative supplier if necessary. (Id.)

In 2011, after the parties’ business relationship had deteriorated, 

plaintiff learned defendant’s website was potentially infringing several 

of plaintiff’s trademarks. (Dkt. 56 at 16; Dkt. 56-16 at 7.) The parties 

settled this dispute in 2012, and entered into a Settlement Agreement. 

(Dkt. 95-2.) The Agreement prohibited defendant from using plaintiff’s 

trademarks on its website. (Id.) Subsequently, in 2015, plaintiff learned 

defendant was using the name Ziebart in the meta tags1 of its website. 

Plaintiff brings a breach of contract claim alleging that the references to 

its trademarks in the meta tags of defendant’s website constitute a 

breach of the Settlement Agreement.

II. Defendant’s Motion for Summary Judgment

Defendant asks the Court to grant summary judgment on three 

issues. First, it seeks a determination that it purchased the trademark 

for Formula Q in the 1996 APA. Second, it moves the Court to affirm 

that since it owns the trademark for Formula Q, it cannot be subjected to

 

1 Meta tags are words or phrases describing a web page’s content and appear in the 

page’s code, but do not appear on the page itself. The tags can be read by search 

engines so the web page will appear in search results.

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 4 of 19 Pg ID 2535
5

liability for trademark infringement. Finally, it seeks judicial 

cancellation of Ziebart’s 2015 application for the Formula Q trademark. 

Plaintiff responds by arguing that it never sold the Formula Q 

trademark to defendant, and that defendant’s motion is based on a 

misreading of the documents surrounding plaintiff’s 1996 sale of ZPG to 

defendant.

A trademark is “any word, name, symbol, or device . . . used by a 

person . . . to identify and distinguish his or her goods, including a unique 

product, from those manufactured or sold by others and to indicate the 

source of the goods . . .” 15 U.S.C. § 1127. The Lanham Act protects a 

trademark owner from infringement, regardless of whether the 

trademark is registered with the Patent and Trademark Office. Fuji

Kogyo Co., Ltd. V. Pacific Bay Int’l., Inc., 461 F.3d 675, 682-83 (6th Cir. 

2006). It does so in order to prevent customer confusion and ensure the 

quality of goods in the market by prohibiting infringers from “passing off 

a good or service as having been produced by another.” NetJets Inc. v. 

IntelliJet Group, LLC, 602 F. App’x 242, 243 (6th Cir. 2015).

A “bedrock principle[] of trademark law is that trademark . . . 

ownership is not acquired by federal or state registration. Rather, 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 5 of 19 Pg ID 2536
6

ownership rights flow only from prior appropriation and actual use in the 

market.” Allard Enter., Inc., v. Advanced Programming Res., Inc., 146 

F.3d 350, 356 (6th Cir. 1998) (quoting Homeowners Group, Inc. v. Home 

Mktg. Specialists, Inc., 931 F.2d 1100, 1105 (6th Cir. 1991)) (internal 

quotations omitted). A party establishes actual use and a right in an 

unregistered trademark “by demonstrating that its use of the mark was 

‘deliberate and continuous, not sporadic, casual, or transitory.’” Circuit 

City Stores, Inc. v. CarMax, Inc., 165 F.3d 1047, 1054-55 (6th Cir. 1999)

(quoting La Societe Anonyme des Parfums le Galion v. Jean Patou, Inc., 

495 F.2d 1265, 1272 (2d Cir. 1974)). 

As a threshold matter, plaintiff has produced sufficient evidence to 

establish that it owned a common law trademark in the name Formula 

Q prior to the APA. Plaintiff’s president states in a sworn declaration 

that plaintiff has sold Formula Q since 1984, always using plaintiff’s 

name to denote the source of the product. (Dkt. 99-2 at 3.) Plaintiff has 

taken in over $50 million in sales of Formula Q and has not changed the 

name of the product during that time period. (Id.) Such use is “deliberate 

and continuous” and thus establishes common law rights in the mark. 

See Circuit City, 165 F.3d at 1054-55.

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 6 of 19 Pg ID 2537
7

What is more, plaintiff’s actions indicate that trademark rights 

from the continuous use and sale of Formula Q vested in plaintiff not 

ZPG. Neither ZPG nor defendant was able to sell chemicals labeled

Formula Q to customers other than plaintiff without plaintiff’s 

permission. (Dkt. 99-2 at 4; see also Dkt. 110-4 at 4 (“ZPG was not 

allowed to call Formula Q, Formula Q.”); Dkt. 93-5 (License Agreement

between plaintiff and defendant that included use of the Formula Q 

name).) During the time period in which ZPG manufactured the chemical 

known as Formula Q, any direct sales of the chemical it made to 

automakers was under the label Formula 1021. (Dkt. 100-4 at 4.) By 

taking these steps to ensure that Formula Q was associated with Ziebart, 

rather than ZPG, plaintiff assigned the trademark rights in the Formula 

Q name to itself and not its subsidiary.

Having established that plaintiff had a common law right in the 

Formula Q trademark prior to the APA, the next question is whether 

plaintiff sold the rights to that mark to defendant in the APA. 

A court’s role in interpreting a contract is to “determine what the 

agreement was and effectuate the intent of the parties.” Hunt v. Drielick, 

496 Mich. 366, 372 (Mich. 2014). Courts will “ascertain the intent of the 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 7 of 19 Pg ID 2538
8

parties from the plain and unambiguous language of a contract.” 

Michigan Bell Tel. Co. v. MCIMetro Access Transmission Serv., Inc., 323 

F.3d 348, 357 (6th Cir. 2003) (citing Haywood v. Fowler, 190 Mich. App. 

253, 258 (Mich. Ct. App. 1991)). In doing so, “[c]ourts must construe 

contracts as a whole.” Id. (internal quotations omitted). In addition, 

“where one writing references another instrument for additional contract 

terms, the two writings should be read together.” Naturipe Foods, LLC 

v. Siegel Egg Co., No. 327172, 2016 WL 4723312, at *2 (Mich. Ct. App. 

Sept. 8, 2016), appeal denied, 500 Mich. 1021 (2017) (quoting Forge v. 

Smith, 458 Mich. 198, 207 (Mich. 1998)).

Reading the APA as a whole and ascertaining its intent from the 

plain language of the contract, the parties could not have intended for 

defendant to purchase the Formula Q trademark. 

Defendant points to language in the contract indicating that it 

purchased “all of the assets of Seller currently used by Seller at the 

Facility or elsewhere in connection with the business conducted at the 

Facility which are necessary, important or useful to the business 

conducted at the facility as set forth in Schedule 2.1.” (Dkt. 93-1 at 11-

12.) Neither party could produce Schedule 2.1 – the list of assets to be 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 8 of 19 Pg ID 2539
9

transferred – during litigation, and defendant contends that the 

trademark would have been listed therein. (Dkt. 93 at 17.) Even so, 

defendant posits “[n]o reasonable trier of fact would conclude that the 

trademark for Formula Q, when not listed as an excluded asset, is not 

‘necessary, important or useful to the business’ of manufacturing 

Formula Q . . .” Further, according to defendant, plaintiff agreed in the 

APA to “refrain from competing in the Formula Q market for fifteen 

years,” and the APA “could have easily excluded the trademark, but it 

did not.” (Id.) All of this, taken together, indicates that plaintiff intended 

to sell the trademark to defendant.

However, defendant misreads the contract, and, when given its 

plain meaning, the contract could not have involved a sale of the 

trademark from plaintiff to defendant. The APA codified a sale of 

plaintiff’s wholly owned manufacturing subsidiary, ZPG, to defendant. 

(See generally Dkt. 93-1; 93-4.) It is clear from the plain language of the 

APA that it was a transfer of ZPG’s manufacturing rights, know-how, and 

tools from plaintiff to defendant. The contract identifies ZPG, not 

Ziebart, as the “Seller,” and defendant only bought “Seller[‘s]” assets. 

(Dkt. 93-1 at 7, 11.) Defendant could not have purchased the Formula Q 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 9 of 19 Pg ID 2540
10

trademark in the APA because the seller, ZPG, did not own the 

trademark.

Additionally, the parties demonstrated in the APA that if they had 

wished to effect a transfer of all intellectual property rights in Formula 

Q, they knew how to do so. Section 2.1(h) of the APA lists among the 

“assets to be required” the “[p]atents and all specifications, processes, 

know-how . . . formulae, technology, trade secrets, and proprietary 

information relating to . . . the business conducted at the [ZPG] Facility, 

including . . . those items set forth in Schedule 2.1.” (Dkt. 93-2 at 13.) 

That section then goes on to transfer “all intellectual property rights of 

Seller and/or Ziebart in the product developed by Ziebart known as 

Solvent-Based Fire-Resistant Undercoating . . .” (Id. (emphasis added).) 

In other words, the APA transferred only the enumerated set of rights, 

which does not include trademark rights, to products listed in schedule 

2.1, while explicitly transferring “all intellectual property rights” for a 

different, named product. That transfer of all intellectual property 

rights, unlike the transfer of items in Schedule 2.1, included those 

possessed by plaintiff in addition to those possessed by ZPG. Accordingly, 

if the parties had agreed to a transfer of all intellectual property rights 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 10 of 19 Pg ID 2541
11

regarding Formula Q, including those possessed by plaintiff, the APA 

would have said so explicitly.2 

Further, there were exhibits attached to the APA and referenced in 

the language of the contract indicating plaintiff did not sell the Formula 

Q trademark to defendant. Where additional documents are referenced 

in a contract, the “writings should be read together.” See Naturipe Foods, 

2016 WL 4723312 at *2. The two exhibits relevant here are the Supply 

Agreement (Dkt. 93-4) and the License Agreement (Dkt. 93-5). Those two 

exhibits, when read in conjunction with the APA, show plaintiff selling 

 

2 In addition, throughout its briefing, defendant argues that the transfer of rights to 

“product formulas,” “trade secrets,” or “other proprietary information” must have 

included the trademark. However, this argument conflates a trademark with a 

patent. In general, trademark law “protects the goodwill represented by particular 

marks, enabling consumers readily to recognize products and their source and to 

prevent consumer confusion between products and between sources of products.” 74 

Am. Jur. 2d Trademarks and Tradenames § 1. In contrast, patent law relates to

manufacturing, and grants a “statutory . . . monopoly that gives an inventor the 

exclusive right to make, use, and sell one's invention during the patent's 

duration, and the right to exclude all others from doing so.” 60 Am. Jur. 2d Patents 

§ 6.

Here, defendant purchased rights relating to manufacture, not rights relating to 

sales. Defendant became the sole owner of the recipe for Formula Q, and the APA

explicitly disallowed defendant from selling products made using that recipe to 

anyone but plaintiff, except in certain circumstances. Plaintiff retained the right to 

then label and market the product as Formula Q, with the intent to identify itself as 

the source of the product. For this reason, among others as set forth above, the Court 

concludes that the trademark was not included within these terms in the APA.

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 11 of 19 Pg ID 2542
12

its manufacturing arm to defendant, which would continue to produce 

products for sale by plaintiff as the sole supplier of those products. 

Plaintiff would then label the products with its own branding and sell 

them to its own customers. The Supply Agreement prohibited defendant 

from selling the product directly to plaintiff’s customers (Dkt. 93-4 at 8 

(“Z-Tech shall not . . . solicit, directly or indirectly, Ziebart or Ziebart Tidy 

Car franchisees product sales.”), and the Licensing Agreement explicitly 

defined the parties’ rights with regards to trademarks and branding. 

(Dkt. 93-5.) Specifically, it granted defendant a license to use plaintiff’s 

trademarks in certain, limited sales in the “original equipment 

manufacturing automotive market.” (Dkt. 93-5 at 2.)

Defendant addresses the Licensing Agreement by suggesting that 

it only covers the name Ziebart and “other registered trademarks . . .” 

(Dkt. 93 at 13.) Because Formula Q was not a registered trademark,

defendant argues it was not covered by the Licensing Agreement. 

However, this argument relies on selective quoting of the Agreement. 

That same section, labeled “Recitals,” serves only to acknowledge that 

plaintiff is “engaged in licensing” registered trademarks and that it “uses 

its distinctive Ziebart name and other registered trademarks, 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 12 of 19 Pg ID 2543
13

tradenames, and service marks . . .” (Dkt. 93-5 at 2.) This is not the 

operative portion of the Agreement. Instead, the operative portion of the 

Agreement defines the phrase “trademarks” as “the trademarks, service 

marks, and tradenames” plaintiff uses, and makes no reference to 

whether they are registered.3 (Id. at 3.) Moreover, the Licensing 

Agreement specifically licenses the trademarks associated with the 

assets included in plaintiff’s sale of ZPG to defendant. (Id. at 2.) 

Defendant’s arguments ignore the effect of the Licensing 

Agreement. If defendant’s reading of the documents in this case is correct 

– that the assets sold in the APA included the Formula Q trademark –

then the Licensing Agreement would not have been necessary. Plaintiff, 

the licensor in the Licensing Agreement, could not have licensed its 

trademarks to defendant if it had sold them. Under such a reading, the 

entire Licensing Agreement is superfluous. 

 

3 This section of the Agreement references an “Exhibit A” which purported to list the 

trademarks at issue in the Licensing Agreement. Neither party has produced nor 

referenced Exhibit A in this litigation. However, that provision of the Licensing 

Agreement makes clear that the license applies to the “licensed goods,” which the 

Licensing Agreement earlier defines as “any and all chemicals or products 

manufactured by licensee.” Given that Formula Q is a “chemical or product 

manufactured by licensee,” defendant, the section of the Agreement defining the term 

“trademark” applies to Formula Q. (Dkt. 93-4 at 2.) 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 13 of 19 Pg ID 2544
14

The parties’ course of dealing also indicates that defendant never 

purchased the Formula Q trademark. On June 14, 2000, after the 

parties’ business relationship had ended, plaintiff sent a cease and desist 

letter to defendant demanding that defendant stop using plaintiff’s 

trademarks. Specifically, the letter noted that plaintiff “has common law 

trademark rights in the name[] . . . ‘Formula Q,’” and that defendant’s 

use of plaintiff’s trademarks “is an illegal infringement of those 

trademarks.” (Dkt. 99-11 at 3.) Defendant responded to that letter 

twelve days later, stating it “has no intention of using the Ziebart 

trademark or Zeibart labeled products.” (Dkt. 99-12 at 2.) It did not 

claim ownership of the trademark. (Id.)

In addition, throughout the parties’ supply relationship, plaintiff 

continuously audited the quality of the products defendant supplied it, 

and rejected product that did not meet its quality standards. A 

trademark owner can abandon its rights when its actions are such that 

“the mark can no longer provide a meaningful assurance of quality.” 

Tumblebus Inc. v. Cranmer, 399 F.3d 754, 764 (6th Cir. 2005) (quoting 

RESTATEMENT (THIRD) OF UNFAIR COMPETITION § 33 cmt. b 

(1995)). Plaintiff, in this case, zealously guarded the quality of Formula 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 14 of 19 Pg ID 2545
15

Q that defendant produced and returned product that was not up to its 

standards. (Dkt. 99-15.) Such behavior is consistent with a trademark 

owner protecting its rights and avoiding abandonment.

For the reasons set forth above, plaintiff owned a common law right 

in the Formula Q trademark and never sold those rights to defendant. 

Thus, defendant was never the owner of the Formula Q trademark. For 

this reason, defendant’s motion for summary judgment on its claim that 

it was the owner of the Formula Q mark is denied. Because summary 

judgment on this claim is denied, summary judgment is also denied with 

respect to defendant’s other claims – that it cannot be subject to liability 

for trademark infringement and cancellation of plaintiff’s trademark 

application – because both of those claims are premised on defendant’s 

ownership of the trademark.

III. Plaintiff’s Motion for Summary Judgment

Plaintiff moves for summary judgment on its breach of contract 

claim, alleging that defendant breached the parties’ 2012 Settlement 

Agreement by failing to remove references to Ziebart and Z-Shield from 

the meta tags of its website. (Dkt. 95 at 7.) Defendant contends that the 

term “website” in the Settlement Agreement referred only to its visible 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 15 of 19 Pg ID 2546
16

website and not the underlying meta tags. (Dkt. 98 at 8-10.) The parties 

also disagree about the showing necessary to prove damages. Plaintiff 

argues that the fact that internet users searching for its products may 

be, instead, directed to defendant’s products is sufficient to establish 

damages in this case. (Dkt. 95 at 8.) Defendant suggests that in order 

for plaintiff to succeed, it must show that someone viewed the meta tags

on defendant’s website and then purchased defendant’s product. (Dkt. 

98 at 11.)

Under Michigan law, a party alleging breach of contract must 

demonstrate “(1) there was a contract (2) which the other party breached 

(3) thereby resulting in damages to the party claiming breach.” MillerDavis Co. v. Ahrens Const., Inc., 495 Mich. 161, 178 (Mich. 2014). When 

conducting this analysis, courts “determine what the agreement was and 

effectuate the intent of the parties.” Hunt, 496 Mich. at 372. Courts will 

“ascertain the intent of the parties from the plain and unambiguous 

language of a contract.” Michigan Bell Tel. Co. 323 F.3d at 357. But, 

when the contract’s “words may reasonably be understood in different 

ways,” the terms are ambiguous and the intent of the parties is a question 

left to the jury. Leonor v. Provident Life and Acc. Co., 790 F.3d 682, 687 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 16 of 19 Pg ID 2547
17

(6th Cir. 2015) (citing Raska v. Farm Bureau Mut. Ins. Co. of Michigan, 

412 Mich. 355, 361-62 (Mich. 1982)). “Whether a contract's terms are 

ambiguous is a question of law for the court to decide.” Scott v. State 

Farm Fire and Cas. Co., 86 F. Supp. 3d 727, 733 (E.D. Mich. 2015) (citing 

Whitehouse Condo. Grp., LLC v. Cincinnati Ins. Co., 569 F. App’x 413, 

416 (6th Cir. 2014)).

Here, the parties disagree over the meaning of the term “website” 

in the 2012 Settlement Agreement. Plaintiff contends that “website” 

includes all parts of the website, including the meta tags not part of the

visible portion of the site. (Dkt. 95 at 7.) Defendant, on the other hand, 

argues that “website” was only intended to cover the portions of the site 

visible to the public. (Dkt. 98 at 8-10.) 

Both Plaintiff’s and defendant’s president (and signer of the 

Settlement Agreement) testified to their respective company’s position 

about the meaning of the term “website.” (Dkt. 98-6 at 5-6; Dkt. 98-7 at 

4-5.) Thomas Wolfe, president of Ziebart, testified “we intended this 

agreement to cover anything on a website. So meta tags would have been 

part of a website, the backup.” (Dkt. 98-6 at 6.) In contrast, Louis 

Breskman, president of Z Technologies, testified that it removed visible 

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 17 of 19 Pg ID 2548
18

references to plaintiff’s trademarks from the website, “and since Ziebart 

agreed that the references they . . . wanted removed were removed, a 

settlement agreement was enacted.” (Dkt. 98-7 at 5.) In addition, the 

settlement agreement does not define any of the terms that it uses, 

including website.

Because the term website “may reasonably be understood in 

different ways,” and the parties did understand it in different ways, the 

language of the settlement agreement is ambiguous. See Leonor 790 F.3d 

at 687. Thus, summary judgment on the question of whether defendant 

breached the contract when it left plaintiff’s trademarks in its meta tags

is denied, and the question of what the term “website” in the settlement 

agreement means must be answered by the jury.

The Court does not reach the parties’ arguments about whether 

plaintiff suffered damages from an alleged breach because the Court 

cannot say whether defendant breached the agreement as a matter of 

law.

Accordingly, plaintiff’s motion is denied.

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 18 of 19 Pg ID 2549
19

IV. Conclusion

For the reasons set forth above, each party’s motion for summary 

judgment is denied.

IT IS SO ORDERED.

Dated: March 13, 2018 s/Judith E. Levy 

Ann Arbor, Michigan JUDITH E. LEVY

United States District Judge

CERTIFICATE OF SERVICE

The undersigned certifies that the foregoing document was served 

upon counsel of record and any unrepresented parties via the Court’s 

ECF System to their respective email or First Class U.S. mail addresses 

disclosed on the Notice of Electronic Filing on March 13, 2018.

s/Shawna Burns

SHAWNA BURNS

Case Manager

5:15-cv-11745-JEL-APP Doc # 102 Filed 03/13/18 Pg 19 of 19 Pg ID 2550